Penn Capital Management’s Allergan plc AGN.PRA Stock Holding History

Penn Capital Management’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-1,025	Closed	-$751K	–	287
2017 Q3	$751K	Sell	1,025 -190	-16%	-$158K	0.05%	222
2017 Q2	$1.05M	Sell	1,215 -35	-3%	-$29.3K	0.08%	192
2017 Q1	$1.06M	Sell	1,250 -10	-0.8%	-$8.29K	0.07%	204
2016 Q4	$959K	Sell	1,260 -112	-8%	-$84.6K	0.06%	220
2016 Q3	$1.13M	Sell	1,372 -30	-2%	-$25.9K	0.08%	222
2016 Q2	$1.17M	Sell	1,402 -6	-0.4%	-$5.01K	0.07%	227
2016 Q1	$1.29M	Sell	1,408 -5	-0.4%	-$4.78K	0.07%	214
2015 Q4	$1.46M	Sell	1,413 -1,628	-54%	-$1.64M	0.06%	219
2015 Q3	$2.87M	Hold	3,041	–	–	0.15%	187
2015 Q2	$3.17M	Buy	+3,041	New	+$3.18M	0.13%	201

Other funds holding AGN.PRA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return

WAM

Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return

Equitec Specialists Chicago, Illinois $708K AUM 25.27% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Penn Capital Management's AGN.PRA Position: Q4 2017 in Review

Penn Capital Management sold out of Allergan plc (AGN.PRA) in Q4 2017, closing a stake of 1,025 shares — an estimated $751K sold.

Penn Capital Management first reported a position in AGN.PRA in Q2 2015 and held it in 10 quarters. The position peaked at $3.17M in Q2 2015. 90 funds tracked by Wall St. Rank hold AGN.PRA as of Q4 2017.

Penn Capital Management reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
Penn Capital Management sold 1,025 Allergan plc shares in Q4 2017, an estimated $751K.
Penn Capital Management first reported a position in Allergan plc in Q2 2015 and held it in 10 quarters.
Penn Capital Management's Allergan plc position peaked at $3.17M in Q2 2015.
90 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on Penn Capital Management's 13F filing for Q4 2017, filed 9 Feb 2018.